Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Osteosarcoma × Eflornithine × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1 Osteosarcoma 1

Interventions

Ifosfamide 2 Etoposide 2 Cyclophosphamide 2 surufatinib 1 fludarabine 1 envafolimab 1 anlotinib 1 Vincristine 1 Topotecan 1 Positron Emission Tomography Computed Tomography 1 Neoadjuvant Therapy 1 Methotrexate 1 Mesna 1 Epirubicin 1 Eflornithine 1 Drug Therapy 1 Doxorubicin 1 Cisplatin 1 Brachytherapy 1 Blood Component Removal 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07321912 2026-01-08

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Milton S. Hershey Medical Center

Phase 2 Not yet recruiting

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡